Clinical Trials Directory

Trials / Conditions / GnRH Antagonist

GnRH Antagonist

8 registered clinical trials studyying GnRH Antagonist — 2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotro
NCT07457164
Antev Ltd.Phase 2
Not Yet RecruitingComparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Unde
NCT05326087
ShangHai Ji Ai Genetics & IVF InstitutePhase 3
CompletedPPOS Protocol Versus GnRH Anatagonist for Expected Normal Responder Patients Undergoing ART : a Randomized Cli
NCT06868576
Kasr El Aini HospitalPhase 3
CompletedComparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Patients Undergoing
NCT04414748
ShangHai Ji Ai Genetics & IVF InstitutePhase 3
CompletedLive Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response
NCT04414761
ShangHai Ji Ai Genetics & IVF InstitutePhase 3
UnknownPreventive Application of GnRH Antagonist on Early OHSS
NCT03188471
First Affiliated Hospital, Sun Yat-Sen UniversityPhase 4
UnknownClomiphene Citrate Plus Gonadotropins and GnRH Antagonist Versus Flexible GnRH Antagonist Protocol Versus Micr
NCT02201914
BioromaPhase 4
CompletedSingle Injection of Ganirelix in Gonadotropin Intrauterine Insemination (IUI) Cycles
NCT01286051
Houston Fertility InstituteN/A